ARTICLE | Company News
Celgene, Novartis deal
January 22, 2001 8:00 AM UTC
The companies will develop a set of selective estrogen receptor modulators (SERMs) discovered by CELG to prevent or treat osteoporosis. CELG received an upfront payment and will be eligible for milest...